Dietary aloin, aloesin, or aloe-gel exerts anti-inflammatory activity in a rat colitis model

Life Sciences

Volumn 88, Issue 11-12, 2011, Pages 486-492

  Park, Mi Young ^a   Kwon, Hoon Jeong ^b   Sung, Mi Kyung ^a  

^a Sookmyung Women's University   (South Korea)

^b Seoul National University   (South Korea)

Author keywords

Aloe gel; Aloesin; Aloin; Inflammation; Ulcerative colitis

Indexed keywords

ALOE GEL; ALOESIN; ALOIN; ANTIINFLAMMATORY AGENT; DEXTRAN SULFATE; INTERLEUKIN 1BETA; LEUKOTRIENE B4; MESSENGER RNA; MYELOPEROXIDASE; PROSTAGLANDIN E2; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ALOE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; COLITIS; COLON; CONTROLLED STUDY; DIET SUPPLEMENTATION; ENZYME ACTIVITY; HISTOLOGY; MALE; NONHUMAN; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RAT;

ALOE; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CHROMONES; COLITIS; COLON; DIET; DIETARY SUPPLEMENTS; DISEASE MODELS, ANIMAL; EMODIN; GELS; GLUCOSIDES; INTERLEUKIN-1BETA; LEUKOTRIENE B4; MALE; PEROXIDASE; PLANT PREPARATIONS; RATS; RATS, SPRAGUE-DAWLEY; TUMOR NECROSIS FACTOR-ALPHA;

ALOE; ANIMALIA; RATTUS;

EID: 79952446275     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2011.01.010     Document Type: Article

References (41)

1. B. Arosio, N. Gagliano, L.M. Fusaro, L. Parmeggiani, J. Tagliabue, and P. Galetti Aloe-emodin quinone pretreatment reduces acute liver injury induced by carbon tetrachloride Pharmacol Toxicol 87 2000 229 233
2. R. Atreya, J. Mudter, S. Finotto, J. Müllberg, T. Jostock, and S. Wirtz Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: evidence in Crohns disease and experimental colitis in vivo Nat Med 6 2000 583 588 (Pubitemid 30305911)
3. F. Borrelli, and A.A. Izzo The plant kingdom as a source of anti-ulcer remedies Phytother Res 14 8 2000 581 591
4. P.P. Bradley, D.A. Priebat, R.D. Christensen, and G. Rothstein Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker J Invest Dermatol 78 1982 206 209 (Pubitemid 12171880)
5. J. Brynskov, N. Tvede, C.B. Andersen, and M. Vilien Increased concentrations of interleukin 1 beta, interleukin-2, and soluble interleukin-2 receptors in endoscopical mucosal biopsy specimens with active inflammatory bowel disease Gut 33 1992 55 58
6. E. Carty, M. De Brabander, R.M. Feakins, and D.S. Rampton Measurement of in vivo rectal mucosal cytokine and eicosanoid production in ulcerative colitis using filter paper Gut 46 2000 487 492 (Pubitemid 30305812)
7. G. Cipolla, F. Crema, S. Sacco, E. Moro, F. de Ponti, and G. Frigo Nonsteroidal anti-inflammatory drugs and inflammatory bowel disease: current perspectives Pharmacol Res 46 2002 1 6 (Pubitemid 35300786)
8. H.S. Cooper, S.N. Murthy, R.S. Shah, and D.J. Sedergran Clinicopathologic study of dextran sulfate sodium experimental murine colitis Lab Invest 69 1993 238 249
9. K. Eamlamnam, S. Patumraj, N. Visedopas, and D. Thong-Ngam Effects of aloe vera and sucralfate on gastric microcirculatory changes, cytokine levels and gastric ulcer healing in rats World J Gastroenterol 12 2006 2034 2039
10. C.E. Eberhart, and R.N. Dubois Eicosanoids and the gastrointestinal tract Gastroenterology 109 1995 285 301
11. A.W. Ford-Hutchinson Leukotriene B4 in inflammation Crit Rev Immunol 10 1990 1 12
12. S.B. Hanauer Inflammatory bowel disease: epidemiology, pathogenesis, and therapeutic opportunities Inflamm Bowel Dis 12 2006 S3 S9
13. J.P. Heggers, A. Kucukcelebi, D. Listengarten, J. Stabenau, F. Ko, and L.D. Broemeling Beneficial effect of Aloe on wound healing in an excisional wound model J Altern Complement Med 2 1996 271 277 (Pubitemid 126488204)
14. R.J. Hilsden, and M.J. Verhoef Complementary and alternative medicine: evaluating its effectiveness in inflammatory bowel disease Inflamm Bowel Dis 4 1998 318 323 (Pubitemid 128699872)
15. R. Hu, G. Shen, U.R. Yerramilli, W. Lin, C. Xu, and S. Nair In vivo pharmacokinetics, activation of MAPK signaling and induction of phase II/III drug metabolizing enzymes/transporters by cancer chemopreventive compound BHA in the mice Arch Pharm Res 29 2006 911 920 (Pubitemid 44808459)
16. F.C. Huang, R.A. Galemmo Jr., G.B. Poli, K.S. Learn, M.M. Morrissette, and W.H. Johnson Jr. Development of a novel series of (2-quinolinylmethoxy) phenyl-containing compounds as high-affinity leukotriene D4 receptor antagonists. 4. Addition of chromone moiety enhances leukotriene D4 receptor binding affinity J Med Chem 34 1991 1704 1707
17. J.L. Jensen, J. Seeley, and B. Gillin Diabetic foot ulcerations. A controlled, randomized comparison of two moist wound healing protocols: Carrasyn Hydrogel Wound dressing and wet-to-moist saline gauze Adv Wound Care 11 1998 1 4
18. K. Kabashima, T. Saji, T. Murata, M. Nagamachi, T. Matsuoka, and E. Segi The prostaglandin receptor EP4 suppresses colitis, mucosal damage and CD4 cell activation in the gut J Clin Invest 109 2002 883 893 (Pubitemid 34275109)
19. M. Kaplan, E.A. Mutlu, M. Benson, J.Z. Fields, A. Banan, and A. Keshavarzian Use of herbal preparations in the treatment of oxidant-mediated inflammatory disorders Complement Ther Med 15 2007 207 216 (Pubitemid 47250488)
20. J.E. Krawisz, P. Sharon, and W.F. Stenson Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity: assessment of inflammation in rat and hamster models Gastroenterology 87 1984 1344 1350 (Pubitemid 15201434)
21. S. Kumar, B.K. Singh, A.K. Pandey, A. Kumar, S.K. Sharma, and H.G. Raj A chromone analog inhibits TNF-alpha induced expression of cell adhesion molecules on human endothelial cells via blocking NF-kappaB activation Bioorg Med Chem 15 2007 2952 2962 (Pubitemid 46402972)
22. J. Langhorst, I.B. Anthonisen, U. Steder-Neukamm, R. Lüdtke, G. Spahn, and A. Michalsen Amount of systemic steroid medication is a strong predictor for the use of complementary and alternative medicine in patients with inflammatory bowel disease: results from a German national survey Inflamm Bowel Dis 11 2005 287 295 (Pubitemid 40439683)
23. H.J. Lin, P.D. Chao, S.Y. Huang, L. Wan, C.J. Wu, and F.J. Tsai Aloe-emodin suppressed NMDA-induced apoptosis of retinal ganglion cells through regulation of ERK phosphorylation Phytother Res 21 2007 1007 1014 (Pubitemid 350190292)
24. M.S. Malo, S. Biswas, M.A. Abedrapo, L. Yeh, A. Chen, and R.A. Hodin The pro-inflammatory cytokines, IL-1beta and TNF-alpha, inhibit intestinal alkaline phosphatase gene expression DNA Cell Biol 25 2006 684 695 (Pubitemid 46052614)
25. M. Mazzei, R. Dondero, E. Sottofattori, E. Melloni, and R. Minafra Inhibition of neutrophil O(2)(-) production by unsymmetrical methylene derivatives of benzopyrans: their use as potential anti-inflammatory agents Eur J Med Chem 36 2001 851 861 (Pubitemid 34033697)
26. H. Ogata, and T. Hibi Cytokine and anti-cytokine therapies for inflammatory bowel disease Curr Pharm Des 9 2003 1107 1113 (Pubitemid 36443211)
27. H. Ohnishi, N. Miyahara, and E.W. Gelfand The role of leukotriene B(4) in allergic diseases Allergol Int 57 2008 291 298
28. K.A. Papadakis, and S.R. Targan Role of cytokines in the pathogenesis of inflammatory bowel disease Annu Rev Med 51 2000 289 298 (Pubitemid 30216038)
29. Y.G. Park, M.Y. Park, M.K. Sung, and H.J. Kwon Study on the intake pattern of health intended foods depending on inclusion of proclaimed health functional food materials J Korean Soc Food Sci Nutr 34 2005 374 379
30. M.Y. Park, H.J. Kwon, and M.K. Sung Evaluation of aloin and aloe-emodin as anti-inflammatory agents in aloe by using murine macrophages Biosci Biotechnol Biochem 73 2009 828 832
31. M.Y. Park, H.J. Kwon, and M.K. Sung Intestinal absorption aloin, aloe-emodin, and aloesin; a comparative study using two in vitro absorption models Nutr Res Pract 3 2009 9 14
32. P. Rawsthorne, F. Shanahan, N.C. Cronin, P.A. Anton, R. Löfberg, and L. Bohman An international survey of the use and attitudes regarding alternative medicine by patients with inflammatory bowel disease Am J Gastroenterol 94 1999 1298 1303 (Pubitemid 29214645)
33. G. Sener, C. Kapucu, S. Cetinel, E. Cikler, and G. Ayanoǧlu- Dülger Gastroprotective effect of leukotriene receptor blocker montelukast in alendronat-induced lesions of the rat gastric mucosa Prostaglandins Leukot Essent Fatty Acids 72 2005 1 11 (Pubitemid 39642190)
34. J.N. Sharma, and L.A. Mohammed The role of leukotrienes in the pathophysiology of inflammatory disorders: is there a case for revisiting leukotrienes as therapeutic targets? Inflammopharmacol 14 2006 10 16
35. R.M. Shelton Aloe vera. Its chemical and therapeutic properties Int J Dermatol 30 1991 679 683
36. G. Speranza, C.F. Morelli, A. Tubaro, G. Altinier, L. Durì, and P. Manitto Aloeresin I, an anti-inflammatory 5-methylchromone from cape aloe Planta Med 71 2005 79 81 (Pubitemid 40223357)
37. R.B. Stein, and S.B. Hanauer Comparative tolerability of treatments for inflammatory bowel disease Drug Saf 23 2000 429 448
38. N. Takzare, M.J. Hosseini, G. Hasanzadeh, H. Mortazavi, A. Takzare, and P. Habibi Influence of Aloe Vera gel on dermal wound healing process in rat Toxicol Mech Methods 19 1 2009 73 77
39. D.R. Thomas, P.S. Goode, K. LaMaster, and T. Tennyson Acemannan hydrogel dressing versus saline dressing for pressure ulcers. A randomized, controlled trial Adv Wound Care 11 1998 273 276
40. A. Wiercińska-Drapało, R. Flisiak, and D. Prokopowicz Effects of ulcerative colitis activity on plasma and mucosal prostaglandin E2 concentration Prostaglandins Other Lipid Mediat 58 1999 159 165 (Pubitemid 29518459)
41. M.Q. Zhang, Y. Wada, F. Sato, and H. Timmerman (Piperidinylalkoxy) chromones: novel antihistamines with additional antagonistic activity against leukotriene D4 J Med Chem 38 1995 2472 2477